Denali Therapeutics Inc. ( DNLI) - Stock Earnings
DNLI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -126.9 million USD | — USD |
| 2025Q4 | -128.5 million USD | — USD |
| 2026Q1 | -128.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DNLI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -145.2 million USD | 330.5 million USD |
| 2024 | -422.8 million USD | — USD |
| 2025 | -512.5 million USD | — USD |
| 2026 Est. | — | — |
DNLI
Price: $21.66
52 week price:
Earnings Per Share: -2.88 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 517900
Market Capitalization: 3.1 billion